Pharmaceutical compositions
Grant
US12576071B2
Kind: B2
Mar 17, 2026
Assignee
XSPRAY PHARMA AB
Inventors
Magnus Brisander, Mustafa Demirbüker, Gérald Jesson, Martin Malmsten, Helene Dérand
Abstract
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.
CPC Classifications
A61K 31/437
A61K 31/44
A61K 31/4439
A61K 31/444
A61K 31/4545
A61K 31/506
A61K 31/517
A61K 31/5377
A61K 47/32
A61K 47/38
A61K 9/0053
A61K 9/14
A61K 9/1641
A61K 9/1652
A61K 9/5138
A61K 9/5146
A61K 9/5161
A61K 9/5192
A61P 27/02
A61P 35/00
A61P 35/02
A61P 43/00
A61P 9/00
A61P 9/10
Filing Date
2024-12-02
Application No.
18964814
Claims
30